BROWSE BY
0
Fennec Pharmaceuticals Banner Image

Fennec Pharmaceuticals

  • Ticker FENC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Fennec Pharmaceuticals Logo Image
  • 1-10 Employees
  • Based in Research Triangle Park, North Carolina
Fennec Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients. STS has received Orphan Drug Designation in the US in this setting.
Visit website
REPORT RATINGS
4.8 / 5.0 (160)

Fennec Pharmaceuticals reports have an aggregate usefulness score of 4.8 based on 160 reviews.

Fennec Pharmaceuticals

Most Recent Annual Report

Fennec Pharmaceuticals
MOST RECENT 2023 Annual Report and Form 10K
View PDF View Form 10K (HTML)

Older/Archived Annual Reports

Show 5 older reports
x
Fennec Pharmaceuticals Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!